AMRN: Amarin Corp. Plc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 5,438.79
Book Value ($M) 140.87
Book Value / Share 0.43
Price / Book 39.26
NCAV ($M) 123.95
NCAV / Share 0.37
Price / NCAV 44.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.72
Return on Equity (ROE) 1.79

Liquidity (mrq)
Quick Ratio 1.84
Current Ratio 2.20

Balance Sheet (mrq) ($M)
Current Assets 355.32
Assets 372.24
Liabilities 231.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -108.22
Net Income -116.44
Earnings Per Share Basic -0.39
Earnings Per Share Basic And Diluted -0.39
Earnings Per Share Diluted -0.39

Cash Flow Statement (mra) ($M)
Cash From Operations -94.70
Cash from Investing -0.06
Cash from Financing -0.06

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-14 13G/A Consonance Capital Management LP 2.93 -61.39
2019-02-13 13G/A Baker Brothers Advisors LP 13.20 6.43
2016-02-16 13G/A Aristeia Capital Llc 3.73
2016-02-12 13G Stonepine Capital, L.p. 0.00
2016-02-12 13G/A Camber Capital Management LLC

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-07-31 10-Q AMRN / Amarin Corp. Plc 10-Q – Quarterly Report – 10-Q
2019-05-01 10-Q AMRN / Amarin Corp. Plc 10-Q Quarterly Report 10-Q
2019-02-27 10-K AMRN / Amarin Corp. Plc 10-K (Annual Report)
2018-11-01 10-Q AMRN / Amarin Corp. Plc 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
AMBI – Ambit Biosciences Corp AMGN – Amgen Inc.
AMPH – Amphastar Pharmaceuticals, Inc. ANAC – Anacor Pharmaceuticals, Inc.
ANIP – ANI Pharmaceuticals, Inc.


Financial data and stock pages provided for FREE by
Fintel.io